Mitchell B Berger1, Daniel M Morgan. 1. Division of Gynecology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-5276, USA. mitcberg@umich.edu
Abstract
BACKGROUND: Periurethral masses after injection of Durasphere bulking material have been previously reported to occur within 12 to 18 months of administration of the agent. METHODS: We present a case report of an anterior vaginal wall mass resulting from a pseudoabscess containing Durasphere agent 5 years after injection. A literature review of urethral bulking agent complications and imaging is also provided. RESULTS: The patient's anterior vaginal wall mass was thought to be due to a pseudoabscess secondary to injection of bulking agent. Pelvic imaging was helpful both in identifying the mass and in surgical planning. The patient was successfully treated by outpatient transvaginal resection of the material. CONCLUSIONS: Urethral bulking agents, although generally safe and effective in the treatment of stress urinary incontinence, can lead to formation of pseudoabscesses. Although these are usually recognized within the first 18 months after injection, they may not be identified until several years later.
BACKGROUND: Periurethral masses after injection of Durasphere bulking material have been previously reported to occur within 12 to 18 months of administration of the agent. METHODS: We present a case report of an anterior vaginal wall mass resulting from a pseudoabscess containing Durasphere agent 5 years after injection. A literature review of urethral bulking agent complications and imaging is also provided. RESULTS: The patient's anterior vaginal wall mass was thought to be due to a pseudoabscess secondary to injection of bulking agent. Pelvic imaging was helpful both in identifying the mass and in surgical planning. The patient was successfully treated by outpatient transvaginal resection of the material. CONCLUSIONS: Urethral bulking agents, although generally safe and effective in the treatment of stress urinary incontinence, can lead to formation of pseudoabscesses. Although these are usually recognized within the first 18 months after injection, they may not be identified until several years later.
Authors: Christina I Poon; Philippe E Zimmern; Tracey S Wilson; Gina A Defreitas; Melissa R Foreman Journal: Urology Date: 2005-01 Impact factor: 2.649
Authors: D Lightner; C Calvosa; R Andersen; I Klimberg; C G Brito; J Snyder; D Gleason; D Killion; J Macdonald; A U Khan; A Diokno; L T Sirls; D Saltzstein Journal: Urology Date: 2001-07 Impact factor: 2.649